Publications by authors named "Tomoe Akagami"

Claim this Profile
N
Non-exercise Activity Thermogenesis Correlated With Clinical Parameters in Patients With or At-Risk for Chronic Obstructive Pulmonary Disease (COPD): A Pilot Study.
Sanehiro Yogi, Toru Shirahata, Hideaki Sato, Yuki Nishida, Kaiji Inoue, Tomoe Akagami

Cureus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of sleep parameters by titration polysomnography could predict adherence to positive airway pressure therapy in obstructive sleep apnea.
Toru Shirahata, Yoshitaka Uchida, Takahiro Uchida, Shun Shinomiya, Hideaki Sato, Tomoe Akagami

J Clin Sleep Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of bunashimeji mushroom-induced hypersensitivity pneumonitis diagnosed by inhalational provocation test in a hospital room.
Tomoe Akagami, Kazuyuki Nakagome, Sotaro Takagi, Susumu Yamazaki, Shohei Minezaki

Respirol Case Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Yuji Minegishi, Tomoe Akagami, Makoto Arai, Ryota Saito, Daisuke Arai

Lung Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible association of high-density lipoprotein cholesterol levels with trunk muscle deficits and decrease in energy expenditure in patients with or at risk for COPD: A pilot study.
Toru Shirahata, Hideaki Sato, Sanehiro Yogi, Kaiji Inoue, Mamoru Niitsu, Tomoe Akagami

Respir Investig· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of non-exercise activity thermogenesis on physical activity in patients with COPD.
Toru Shirahata, Yuki Nishida, Hideaki Sato, Sanehiro Yogi, Tomoe Akagami

Sci Prog· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
Ken Naganuma, Hisao Imai, Ou Yamaguchi, Kosuke Hashimoto, Tomoe Akagami

Chemotherapy· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of post-progression survival on overall survival in patients receiving nivolumab monotherapy as a second-line treatment for advanced non-small cell lung cancer.
Hisao Imai, Ou Yamaguchi, Keita Mori, Kosuke Hashimoto, Tomoe Akagami

Thorac Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy expenditure and physical activity in COPD by doubly labelled water method and an accelerometer.
Hideaki Sato, Hidetoshi Nakamura, Yuki Nishida, Toru Shirahata, Sanehiro Yogi, Tomoe Akagami

ERJ Open Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers.
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Tomoe Akagami

Front Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab.
Ou Yamaguchi, Kyoichi Kaira, Shun Shinomiya, Atsuto Mouri, Kosuke Hashimoto, Tomoe Akagami

Thorac Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD.
Toru Shirahata, Hideaki Sato, Sanehiro Yogi, Kaiji Inoue, Mamoru Niitsu, Tomoe Akagami

Respir Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.
Yu Miura, Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Tomoe Akagami

Thorac Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis